Abstract

Fibromyalgia syndrome (FMS) is a complex medical condition characterized by widespread musculoskeletal pain. To date, no gold standard treatment has been developed, and persons with FMS often seek alternative methods to control their symptoms, such as dietary supplements (DS). This study aimed to describe the use of DS in persons living with FMS and examine the associations between the use of DS and its potential predictors. We recruited a convenience sample of 504 participants (≥18 years) living with FMS. The main outcome variables included estimated expenditure on DS in the last 12 months in Norwegian kroner (NOK) and the differences between the groups of users and non-users of DS. Of the 504 participants, 430 reported having used DS, and the mean amount of money spent in the previous year was determined to be NOK 2300. The most common DS reported were vitamin D, magnesium, and omega-3 fatty acids. The predictors of being a DS user were high education, high self-reported knowledge of DS but low overall knowledge of health claims. Users of DS marketed for muscles/joints appear to spend more money on DS. The increasing availability of DS and aggressive advertising in the media through health claims stipulate the need for interventions that lead to informed decisions about DS.

Highlights

  • Its objective is to deliver a forum for the exchange of knowledge and experiences of persons affected by Fibromyalgia syndrome (FMS), as well as to promote their voices at the national level

  • All the participants were suffering from FMS (n = 504); over 60% had one or more additional diagnoses

  • Our study showed that the use of dietary supplements (DS) was common among a convenience sample of persons living with FMS in Norway and their yearly expenditure on DS was relatively high, and higher than compared with the normal population, confirming our first hypothesis

Read more

Summary

Introduction

Fibromyalgia syndrome (FMS) is a complex medical condition characterized by widespread musculoskeletal pain. This study aimed to describe the use of DS in persons living with FMS and examine the associations between the use of DS and its potential predictors. We recruited a convenience sample of 504 participants (≥18 years) living with FMS. Of the 504 participants, 430 reported having used DS, and the mean amount of money spent in the previous year was determined to be NOK 2300. The predictors of being a DS user were high education, high self-reported knowledge of DS but low overall knowledge of health claims.

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call